Home
Pulmonx

Pulmonx Market Share Analysis for March 2026

Contactez Pulmonx pour obtenir des informations sur la valve pulmonaire à propos de la valve Zephyr, un traitement peu invasif pour l'emphysème sévère.

Health > Health - Other

Domainpulmonx.com

Year Founded1995

Employees201 - 500

Annual Revenue$50M - $75M

Pulmonx

Pulmonx (including company regionals)

pulmonx.com

See more website traffic and engagement information

Pulmonx Revenue up to March 2026 is 50M - 75M

revenue generated by Pulmonx top domains

Pulmonx top domains revenue over 3 years

Revenue for Pulmonx top domains

pulmonx.com50M - 75M

See more with Sales Intelligence

Total visits to Pulmonx's top domains

Understand Pulmonx market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

pulmonx.com16.6K

See more with Sales Intelligence

Avg. visit duration in Pulmonx's top domains

Analyze Pulmonx engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

pulmonx.com00:01:04

See more with Sales Intelligence

Avg. pageviews on Pulmonx's top domains

See how Pulmonx keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

pulmonx.com1.73

See more with Sales Intelligence

Pulmonx top competitors by domain

Top similar sites in March 2026, ranked by their affinity

vapotherm.comCompany NameVapothermEmployees201 - 500HQUnited States, New Hampshire, ExeterAnnual revenue$100M - $200MTotal visits9KHealth > Health - Other

Top technologies used by Pulmonx

These are the website technologies, by industry, used by Pulmonx top domains

Advertising (18)

Google Adsense

Conversion & Analytics (6)

Google Analytics

Widget (6)

reCAPTCHA

Social (5)

Instagram

More Technologies

12

See all

News & Signals from Pulmonx

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPulmonx Corporation attended event Goldman Sachs 46th Annual Global Health Care Conference on Jun 11th '25.REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) - Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at the Goldman Sachs 46th Annual Global Health Care Conference in Miami on Wednesday, June 11, 2025, at 7:00 AM PT / 10:00 AM ET.

NewsPulmonx Corporation attended event Bank of America Securities 2025 Health Care Conference on May 14th '25.REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) - Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx") a global leader in minimally invasive treatments for severe lung disease, today announced the company will be presenting at the Bank of America Securities 2025 Health Care Conference in Las Vegas on Wednesday, May 14, 2025, at 9:35 AM PT / 12:35 PM ET.

NewsPulmonx Corporation received financing of $219M in initial public offering on Jan 1st '20.Also under his leadership, Pulmonx experienced more than 20% compound annual revenue growth, and in 2020 executed an initial public offering raising $218.5 million.